References
- LeRoy EC, Black C, Fleischmajer F, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–205.
- Blagojevic J, Piemonte G, Benelli L, et al. Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: a challenge for the rheumatologist. J Rheumatol. 2016;43(3):592–598.
- Bohelay G, Blaise S, Levy P, et al. Lower-limb ulcers in systemic sclerosis: a multicentre retrospective case-control study. Acta Derm Venereol. 2018;98(7):677–682.
- Reidy ME, Steen V, Nicholas JJ. Lower extremity amputation in scleroderma. Arch Phys Med Rehabil. 1992;73(9):811–813.
- Shanmugam VK, Price P, Attinger CE, et al. Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol. 2010;747946:2010.
- Nussinovitch U, Shoenfeld Y. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev. 2011;10(5):259–266.
- Meiszterics Z, Timar O, Gaszner B, et al. Early morphologic and functional changes of atherosclerosis in systemic sclerosis–a systematic review. Rheumatol. 2016;55(12):2119–2130.
- Nordin A, Jensen-Urstad K, Björnadal L, et al. Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study. Arthritis Res Ther. 2013;15(4):R87.
- Au K, Singh MK, Bodukam V, et al. Atherosclerosis in systemic sclerosis–a systematic review and meta-analysis. Arthritis Rheum. 2011;63(7):2078–2090.
- Psarras A, Soulaidopoulos S, Garyfallos A, et al. A critical review on cardiovascular risk in systemic sclerosis. Rheumatol Int. 2017;37(1):85–95.
- Trostle DC, Bedetti CD, Steen VD, et al. Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study. Arthritis Rheum. 1988;31(3):393–400.
- Al-Sabbagh MR, Steen VD, Zee BC, et al. Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. J Rheumatol. 1989;16(8):1038–1042.
- Sandmeier B, Jäger VK, Nagy G, et al. Autopsy versus clinical findings in patients with systemic sclerosis in case series from patients of the EUSTAR database. Clin Exp Rheumatol. 2015;33(4 Suppl 91):S75–S79.
- Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327–1339.
- Omarjee L, Fontaine C, Mahe G, et al. Improvement of peripheral artery disease with sildenafil and bosentan combined therapy in a patient with limited cutaneous systemic sclerosis: a case report. Medicine. 2017;96(25):e6988.
- Ichimura Y, Asano Y, Hatano M, et al. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene. Mod Rheumatol. 2011;21(5):548–552.